Background: Preconditioning with the volatile anesthetic isoflurane exerts protective effects in animal models of ischemia. The cytoprotective effects of isoflurane are dependent on the expression of hypoxia inducible factor-1 (HIF-1), a dimeric transcription factor that mediates cellular responses to hypoxia. Methods: We investigated the effect of isoflurane preconditioning on bone marrow stromal cell (BMSC) survival and function. Results: Short exposures to low isoflurane concentrations promoted in vitro survival and migration of BMSCs, whereas long exposures and high doses had the opposite effect. At specific doses and times, isoflurane upregulated the expression of HIF-1α and the stromal-derived factor-1 receptor CXCR4, and induced the activation of Akt, similar to hypoxia, and the effect of isoflurane was abrogated by silencing of HIF-1α or inhibition of PI3K/Akt signaling. In vivo experiments showed that isoflurane preconditioning increased the engraftment of BMSCs into the ischemic brain and improved functional recovery in a mouse model of stroke. Conclusion: Isoflurane preconditioning at specific doses and times improves the survival and function of BMSCs through the upregulation of CXCR4 via a mechanism involving HIF-1α expression and the PI3K/Akt pathway, suggesting that anesthetic preconditioning could be developed as a strategy to improve the efficiency of cell therapy.
Introduction
Isoflurane is a potent volatile anesthetic agent commonly used in clinical practice. Isoflurane has both anti-apoptotic and pro-apoptotic effects under different conditions [1] .
It is cytotoxic in a concentration and time-dependent manner in vitro, inducing neuronal
Cell apoptosis assay Apoptosis assays were performed using an Annexin V-fluorescein isothiocyanate (FITC) apoptosis detection kit (BD Pharmingen, San Diego, CA, USA) according to the manufacturer's instructions. Briefly, cells were resuspended in binding buffer containing Annexin VFITC and propidium iodide and incubated in the dark for 15 min. Cells were analyzed using a FACScan flow cytometer (BD Biosciences, San Jose, CA).
In vitro cell migration assay
BMSCs treated as indicated were seeded on 8 µm pore polycarbonate membrane Boyden chamber inserts in a Transwell plate (Costar, Cambridge, MA) coated with Matrigel (BD Biosciences). DMEM containing 10% FBS was added to the lower chamber, incubated for 24 h at 37°C in a 5% CO 2 incubator, after which the cells on the top surface of the insert were removed with a cotton swab. Cells migrated to the bottom surface of the insert were fixed in 100% methanol for 2 min, stained with hematoxylin and eosin (H&E) and visualized by microscopy (400× magnification). The number of migrating cells was counted in five fields for each condition and represents the average of three independent experiments.
Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated from cells using the Trizol reagent (Invitrogen). Single-stranded cDNA was synthesized from 1 µg of total RNA using a first-strand cDNA synthesis kit (Promega). PCR reactions were performed in a volume of 25 µL containing 1 µL cDNA, 2.5 mM MgCl 2 , 0.25 mM dNTP, 1× PCR buffer, 1 µL of each specific primer and 0.4 µL (2 U) Taq DNA polymerase. The relative purity of the isolated RNA was determined spectrophotometrically and the integrity of the RNA was determined by gel electrophoresis. A total of 2 µg of RNA was retro-transcribed to cDNA using the reverse transcription kit with the following primers:
GAPDH (forward, AGA ACA TCA TCC CTG CAT CC; reverse, CAC ATT GGG GGT AGG AAC AC), CXCR4 (forward, GGC TGT AGA GCG ATG TTT GC; reverse, GTA GAG GTT GAC AGT GTA CA), HIF-1α (forward, GCA GCC AGA TCT CGG CGA AG; reverse, CTG TGT CCA GTT AGT TCA AAC TG); and Akt (forward, ATC GTC GCC AAG GAT GAG GT; reverse, TCT CGT GGT CCT GGT TGT AG) DNA was amplified with an initial denaturation at 94°C for 5 min, followed by 35 reaction cycles (94°C for 1 min, 60°C for 2 min, 72°C for 1 min) and by a final extension at 72°C for 10 min. PCR products were analyzed by electrophoresis on 1.5% agarose gels.
Western blot analysis
Cells were harvested in RIPA lysis buffer supplemented with protease inhibitors. Lysates were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis and proteins were transferred to polyvinylidene difluoride membranes and blocked in TBS with Tween 20 (TBST) containing 5% nonfat dry milk for 2 h at room temperature. Antibodies used and dilutions were as follows: monoclonal anti-HIF-1α (R&D Systems, 1:1000), phospho-Akt (Cell Signaling, 1:1000), total Akt (Santa Cruz Biotechnology, 1:1000), CXCR4 (Santa Cruz Biotechnology, 1:250), anti β-actin (Abcam, 1:2000). After incubation in primary antibodies diluted in TBST with 5% nonfat dry milk at 4°C overnight, membranes were exposed to the corresponding horseradish peroxidase-conjugated secondary antibodies and visualized by enhanced chemiluminescence .
Plasmid construction and cell transfection
The siRNA expression vector for HIF-1α was constructed as described previously [26] (Aminova et al. 2005 ). The specific siRNA sequence targeting HIF-1α was as follows: 5′-TGTGAGCTCACATCTTGAT-3′.
Immunohistochemistry
Immunohistochemical detection of CXCR4 was performed in fixed BMSCs using an antibody against CXCR4 (Chemicon, 1:400), and nuclei were identified by 4,6-diamidino-2-phenylindole dihydrochloride (DAPI) staining.
Middle cerebral artery occlusion model
To generate the rat middle cerebral artery occlusion model (MCAo), rats were anesthetized with 10% (w/v) chloral hydrate at a dose of 3 ml/kg and the right arteries, including the common carotid artery (CCA), external carotid artery (ECA) and internal carotid artery, were isolated. The CCA and ECA were ligated at the proximal end with a bulldog clamp. A monofilament coated with polylysine was inserted into the CCA, the bulldog clamp was released and the monofilament was introduced until meeting slight resistance. Finally, the distal CCA was ligated and the skin was sutured.
Behavioral tests
A modified neurological severity score (mNSS) and foot fault tests were performed at 1, 7, and 14 days after MCAO as described previously [27] . Rats were divided into three groups: MCAO, in which rats were injected intravenously via the caudal vein with 0.2 ml of phosphate-buffered saline (PBS) for control, MCAO+BMSC, in which rats were treated with a BMSC suspension (2 × 10 6 cells) and MCAO+ISO/BMSC, in which rats were treated with BMSCs preconditioned with 2% isoflurane for 4 h. Neurologic function was graded on a scale of 0 to 14, where 0 is the normal score and 14 is the maximal deficit score. For locomotor assessment, mice were tested for placement dysfunction of forelimbs. The total number of steps used to cross the grid was counted and the total number of foot-faults was recorded. The results were expressed as the percentage of foot-faults to the total number of steps.
Histology and immunohistochemistry
Morphological changes in the ischemic brain were observed by staining with 2,3,5-triphenyltetrazolium chloride (TTC) of brain sections as described previously [28] (Zhao et al. 2012 ). Identification of BMSCs was performed by BrdU immunostaining and visualization by H&E staining. In brain sections, the numbers of BrdU-positive BMSCs were counted at 400× magnification under an Olympus BH-2 microscope in the ipsilateral and contralateral hemispheres. PBS was used to replace primary antibodies as a negative control.
Statistical analysis
Results are expressed as the mean ± SD unless otherwise specified. Differences were estimated using one-way analysis of variance (ANOVA) followed by a Student-Newman-Keuls test. P values <0.05 were considered statistically significant. Data analysis was performed using SPCC 17.0 statistical software.
Results

Characterization of BMSCs
BMSCs were expanded for 3 and 4 days after initial seeding ( Fig. 1A and B, respectively) and showed rapid expansion into colonies of confluent spindle-shaped cells. Matrix mineralization and fat droplet formation in cells cultured to passage 3 were visualized by Alizarin red S staining and Oil Red O staining ( Fig. 1C and D, respectively). Cell surface antigen detection by flow cytometry showed that 96.7% of cells were positive for CD90 and 97.9% were positive for CD29, whereas 6.8% of cells reacted with the negative marker CD45, suggesting an almost pure population of BMSCs (Fig. 1E ).
Time and dose dependent effects of isoflurane preconditioning on viability
To examine the effect of isoflurane on BMSC viability, cells were exposed to different doses of isoflurane for different times and cell viability was assessed by the MTT assay. The results showed that low doses and short treatment times increased the viability of BMSCs, whereas long exposure times (>6 h) and high doses (>2%) decreased viability in a dosedependent manner ( Fig. 2A) . Annexin V/PI flow cytometric analysis showed that exposure to isoflurane at increasing doses for 4 h resulted in a significant reduction in the percentage of apoptotic cells at doses of 1% and 2% compared to the control (P < 0.05), and this effect was mimicked by hypoxia, whereas isoflurane induced apoptosis at higher doses (Fig. 2B ). Cells treated with 2% isoflurane for different times showed a significant progressive decrease in 
the isoflurane induced reduction in apoptosis, whereas the hypoxia mimetic dimethyloxalylglycine (DMOG), which stabilizes HIF-1α, had a similar effect than isoflurane, decreasing the number of apoptotic cells (Fig. 2D ).
Time and dose dependent effect of isoflurane on BMSC migration
BMSCs were treated with 2% isoflurane for 2, 4, 6, 12, and 24 h or placed under conditions of hypoxia (3% O 2 ) for 24 h, and cell migration was assessed using the Transwell assay. The results showed that the number of migrating BMSCs increased progressively up to 4 h of isoflurane exposure, whereas longer incubation times resulted in decreased cell migration (Fig. 3A and B) . Exposure of cells to hypoxia increased the number of migrating cells similar to the effect of low-dose isoflurane (P < 0.05). Similar results were obtained when cells were exposed to increasing doses of isoflurane from 1% to 4%, which showed that isoflurane dose-dependently significantly increased BMSC migration at low doses, similar to the effect of hypoxia, whereas high doses (3% and 4%) inhibited BMSC migration (P < 0.05) (Fig. 4A and B) .
Isoflurane preconditioning modulates CXCR4 expression and Akt activation
To further explore the mechanisms underlying the effect of isoflurane on BMSC viability and migratory ability, we examined whether anesthetic preconditioning affected the expression of the SDF-1 receptor CXCR4, HIF-1α, HIF-1β, and Akt signaling, which is known to regulate hypoxia-induced CXCR4 expression [24] . Western blot analysis showed that short time (2 and 4 h) and low dose (1 and 2%) isoflurane treatment upregulated the expression of CXCR4 in a time and dose dependent manner, whereas longer exposures and higher doses progressively restored CXCR4 expression and reduced it to below normal levels in BMSCs (P < 0.05 all, Fig. 5A and B) . Hypoxia upregulated CXCR4 expression to a level similar to that observed in response to 2% isoflurane for 4 h. A similar pattern was observed for HIF-1α expression, which was upregulated by low isoflurane doses and short exposure times, as well as by hypoxia, whereas no effect of isoflurane on the expression of HIF-1β was observed (P < 0.05 all, Fig. 5C and D) . Similarly, Akt was activated by isoflurane at low doses and short exposure times. As shown in Fig. 5E and F, the relative levels of phospho-Akt increased significantly in a dose and time dependent manner up to 2% isoflurane and 2 h exposure, similar to the effect of hypoxia, whereas longer exposures or higher doses returned values to control levels (P < 0.05 all, Fig. 5E and F) .
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Effect of HIF-1α on BMSC migration
To determine the effect of HIF-1α on isoflurane induced BMSC migration, cells were treated with 2% isoflurane for 4 h in the presence or absence of siRNA mediated HIF-1α silencing or DMOG. The results showed that knockdown of HIF-1α abrogated the isoflurane induced increase in BMSC migration, whereas the induction of hypoxia restored the high levels of BMSC migration (Fig. 7A and B) .
Isoflurane preconditioning improves BMSC engraftment and functional recovery in a rat model of stroke
To examine the effects of isoflurane on brain function, we used a rat middle cerebral artery occlusion (MCAO) model to assess behavioral and morphological changes. Figure 8A shows representative images of 3-TTC stained brain sections of sham-operated and MCAO rats. The images show unilateral necrotic areas (white) in MCAO rat brains compared to the evenly stained (red) sections of sham-operated rats, indicating that the MCAO model was established successfully. To determine the effect of isoflurane on brain function in the stroke animal model, rats in the different groups were evaluated by the foot fault test and the modified neurological severity scores (mNSS) at 7 and 14 days after injection of BMSCs as described in the Materials and Methods section. The results showed that injection of BMSCs significantly improved brain function in the MCAO rat model, and isoflurane preconditioning further improved functional recovery in both tests on days 7 and 14 ( Fig.  8B and C) . Knockdown of HIF-1α reversed the effect of isoflurane whereas hypoxia (DMOG) enhanced the effect of BMSC treatment. To determine the effect of isoflurane preconditioning on the delivery of BMSCs into the ischemic brain, the number of BrdU stained cells in the ipsilateral and contralateral hemispheres was counted. The results showed that isoflurane pretreatment significantly improved BMSC engraftment in both hemispheres similar to the effect of DMOG, and this effect was abolished by HIF-1α silencing (Fig. 8E) . Figure 8D shows representative images of H&E stained brain sections, with BrdU-positive BMSCs indicated by arrows.
Discussion
In the present study, we showed that isoflurane preconditioning improved the survival and migratory ability of BMSCs at low doses and during short exposure times, and these effects were mediated by the upregulation of HIF-1α through the activation of PI3K/Akt signaling. Isoflurane upregulated CXCR4 via a mechanism dependent on HIF-1α expression and PI3K/Akt signaling in vitro and promoted BMSC engraftment in the ischemic brain, as well as improving neurological function in a mouse model of stroke in vivo. Taken together, our results suggest that the protective effects of isoflurane are dose and time dependent and are mediated by the upregulation of CXCR4 in a HIF-1α dependent manner through a mechanism involving the PI3K/Akt signaling pathway.
Volatile anesthetics can alter or modulate the expression of genes involved in cell survival in a specific time-and dose-dependent manner. Isoflurane induces the expression of c-jun and c-fos, which are the main components of the transcription factor AP-I complex and thus regulate several aspects of cell physiology in response to stress, in the heart, liver, kidney and brain [29] . Furthermore, isoflurane modulates nuclear factor-κB and Jun N-terminal kinase 1 expression in mice at low doses [30] . In the present study, isoflurane promoted survival at low doses and during short exposure times, whereas it induced cell death and inhibited the function of BMSCs at high doses and long exposure times. The dual effects of isoflurane were reported previously and explained by different mechanisms. Isoflurane was suggested to induce apoptosis by facilitating the release of calcium from the endoplasmic reticulum [31, 32] . However, a protective effect against apoptosis was demonstrated in rat hippocampus cultures [33] , and isoflurane attenuated cytokine-induced cell death in vascular smooth muscle cells and human umbilical vascular endothelial cells [34] . Short exposure to isoflurane increases the levels of the antiapoptotic factor Bcl-2 in rats [14] , whereas long exposure to isoflurane decreases Bcl-2 levels in cultured cells [2] . The sensing of anesthetic volatiles by mammalian cells can lead to phenotypic modifications that favor survival, similar to the sensing of oxygen [10] . Inhalational anesthetics such as isoflurane affect the expression of HIF-1 and HIF-1 responsive genes, which increases the resistance of cells to injury or stress. In the present study, we showed that isoflurane preconditioning upregulated HIF-1α in a PI3K/Akt dependent manner in BMSCs. The upregulation of HIF-1α by isoflurane was shown to have cardioprotective effects in several animal models [13, 35] . Furthermore, in a rabbit model of myocardial ischemiareperfusion injury, the protective effect of isoflurane mediated by the upregulation of HIF-1α was shown to involve the upstream PI3K/Akt/mTOR pathway [9] . In rat models of cerebral ischemia, isoflurane protects against ischemic neuronal injury through the induction of HIF-1α and iNos, and the involvement of the PI3K/Akt pathway in the neuroprotective effect of isoflurane via HIF-1α upregulation was demonstrated in several studies [14, 36, 37] . However, few studies have evaluated the effect of inhalational volatiles on the function of MSCs. A recent study by Sun et al. showed that sevoflurane preconditioning enhanced the survival and migration of MSCs and improved the therapeutic potential of MSCs through the upregulation of HIF-1α and p-Akt [38] , which supports the results of the present study.
In the present study, the effect of isoflurane on promoting BMSC viability and migration, increasing CXCR4 levels and activating Akt was similar to the effect of hypoxia and was mediated by the upregulation of HIF-1α. Sub-lethal hypoxia exposure increases the tolerance and regenerative properties of many stem/progenitor cells [39] [40] [41] [42] , and cells preconditioned by hypoxia show increased survival after transplantation into the ischemic brain through the upregulation of HIF-1α, SDF-1 and CXCR4 among other factors [43] . Transplanted cells preconditioned by hypoxia show enhanced homing ability through the upregulation of CXCR4 [40, 41] , and improve functional recovery in animal models of stroke [41, 44] . These studies support the present findings, which indicate that the protective effect of isoflurane is mediated by the upregulation of HIF-1α.
BMSCs have shown regenerative potential in models of myocardial, limb and brain ischemia, and when administered systemically, BMSCs migrate to the site of injury, promoting the regeneration of damaged tissues [17, 28, 45] . In the present study, we showed that isoflurane preconditioning upregulated the expression of CXCR4 via a mechanism dependent on HIF-1α expression and the activity of the PI3K/Akt pathway. Furthermore, isoflurane increased the engraftment of BMSCs into the ischemic brain and improved functional recovery in a mouse model of stroke, and these effects were abrogated by HIF-1α silencing. Taken together, our results suggested that the effect of isoflurane preconditioning on the survival and protective function of BMSCs was mediated by the upregulation of CXCR4 via a HIF-1α dependent pathway. This finding is important because a significant challenge in the application of cell-based therapies is to improve the homing and engraftment efficiency of stem cells. SDF-1 and CXCR4 are important for the homing, chemotaxis, engraftment, and survival of different stem cells [46, 47] . In a rat model of myocardial infarction, SDF-1 and CXCR4 were shown to mediate the migration of BMSCs towards the infarcted areas of the heart via activation of the PI3K/Akt pathway [48] . The interaction between SDF-1 and CXCR4 was shown to underlie the trafficking of transplanted MSCs to impaired sites in the brain in a rat model of left hypoglossal nerve injury [23] . Furthermore, BMSCs overexpressing CXCR4 migrate towards SDF1α, and injection of recombinant SDF1α promotes the migration of BMSCs to the site of injection in the brain [23, 49] . These findings indicate that the overexpresion of CXCR4 may be an effective strategy to improve the migration, survival and engraftment of BMSCs, underscoring the importance of our findings showing the effect of isoflurane preconditioning on the expression of CXCR4. Furthermore, these studies support the hypothesis that the mechanism underlying the protective effects of isoflurane in the brain may involve chemokine upregulation mediated by HIF-1α expression and Akt activation, as shown in the present study. 
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In conclusion, we showed that isoflurane preconditioning promotes the survival of BMSCs through the upregulation of HIF-1α via the PI3K/Akt pathway, and its protective effects in the ischemic brain are mediated by the upregulation of CXCR4, leading to enhanced migratory ability and engraftment of BMSCs at sites of ischemia. Our findings suggest that isoflurane preconditioning at specific doses and exposure times enhances the neuroprotective effects of MSCs and could be a beneficial strategy to improve the efficiency of cell therapy.
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